M&A

In surprise switch, Bristol-Myers is selling off blockbuster Otezla, promising to complete Celgene acquisition — just later
In surprise switch, Bristol-Myers is selling off blockbuster Otezla, promising to complete Celgene acquisition — just later
Endpoints
Bristol-Myers Squibb
Opdivo
Otezla
M&A
FTC
Celgene
Flag link:
These 3 Biotech Stocks Skyrocketed Last Week
These 3 Biotech Stocks Skyrocketed Last Week
Motley Fool
Array Biopharma
Pfizer
M&A
G1 Therapeutics
trilaciclib
Cel-Sci
Flag link:
Hologic Sets M&A Sights on SuperSonic Imagine in $85M Deal
Hologic Sets M&A Sights on SuperSonic Imagine in $85M Deal
Medical Devices and Diagnostics Industry
Hologic
M&A
SuperSonic Imagine
devices
breast imaging
Flag link:
What Should Celgene's Investors Do With Everything Bristol-Meyer Squibb Is Giving Them?
What Should Celgene's Investors Do With Everything Bristol-Meyer Squibb Is Giving Them?
Motley Fool
Bristol-Myers Squibb
Celgene
M&A
Flag link:
Pharmacquired: Is $11B enough to secure Sanofi's spot in hemophilia?
Pharmacquired: Is $11B enough to secure Sanofi's spot in hemophilia?
Biopharma Dive
Sanofi
M&A
Bioverativ
hemophilia
gene therapy
Flag link:
GSK consumer health sell-off ahead of Pfizer joint venture
GSK consumer health sell-off ahead of Pfizer joint venture
Pharmaforum
GSK
M&A
Pfizer
consumer health
Flag link:
Investor day prep at Merck includes a new strategy to pick up the pace on M&A
Investor day prep at Merck includes a new strategy to pick up the pace on M&A
Endpoints
Merck
investors
Keytruda
cancer
M&A
Flag link:
Array-size deals don’t come around too often
Array-size deals don’t come around too often
EP Vantage
M&A
Pfizer
Array Biopharma
Flag link:
3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer's Surprise Deal
3 Big Drugmakers Most Likely to Make Acquisitions After Pfizer's Surprise Deal
Motley Fool
Pfizer
Array Biopharma
M&A
Amgen
Gilead Sciences
Biogen
Flag link:
Zoll Acquires TherOx for Undisclosed Sum
Zoll Acquires TherOx for Undisclosed Sum
Medical Devices and Diagnostics Industry
ZOLL Medical
devices
TherOx
M&A
Flag link:
Why Pfizer's Acquisition of Array BioPharma Won't Pay Off Anytime Soon
Why Pfizer's Acquisition of Array BioPharma Won't Pay Off Anytime Soon
Motley Fool
Pfizer
Array Biopharma
M&A
Flag link:
Pfizer Nabs Array Biopharma in $11.4 Billion Takeover of Cancer Drug Specialist
Pfizer Nabs Array Biopharma in $11.4 Billion Takeover of Cancer Drug Specialist
TheStreet.com
Pfizer
Array Biopharma
M&A
cancer
colorectal cancer
Flag link:
Dr. Reddy’s to sell neurology branded products to Upsher-Smith Laboratories
Dr. Reddy’s to sell neurology branded products to Upsher-Smith Laboratories
Pharmaceutical Business Review
Dr Reddy's
M&A
Upsher-Smith
neurology
Flag link:
Cue the M&A chatter: UniQure is scouting for a buyout deal as gene therapy field sizzles — report
Cue the M&A chatter: UniQure is scouting for a buyout deal as gene therapy field sizzles — report
Endpoints
uniQure
M&A
gene therapy
Flag link:
Merck's Full Court Press On Oncology
Merck's Full Court Press On Oncology
Forbes
Merck
oncology
R&D
M&A
Tilos Therapeutics
Flag link:
Dassault Puts Down $5.8B for Medidata Solutions
Dassault Puts Down $5.8B for Medidata Solutions
Medical Devices and Diagnostics Industry
Dassault Systemes
Medidata Solutions
M&A
clinical trials
devices
Flag link:
FTC demands could mean months-long delay for Roche-Spark deal
FTC demands could mean months-long delay for Roche-Spark deal
Biopharma Dive
Roche
Spark Therapeutics
FTC
M&A
Flag link:
Investors fret as new regulatory probes spur fresh delays to Roche's $4.3B Spark buyout
Investors fret as new regulatory probes spur fresh delays to Roche's $4.3B Spark buyout
Endpoints
Spark Therapeutics
Roche
FTC
UK
M&A
Flag link:
Merck Bags Tilos, Adding an Immunotherapy Booster to Its Arsenal
Merck Bags Tilos, Adding an Immunotherapy Booster to Its Arsenal
Xconomy
Merck
M&A
Tilos Therapeutics
cancer immunotherapy
oncology
Flag link:
#BIO2019: Taking the Pulse of Dealmakers: 2019 Outlook
#BIO2019: Taking the Pulse of Dealmakers: 2019 Outlook
BIOTechNow
biotech
M&A
Flag link:

Pages